Covalon Technologies Ltd
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more
Covalon Technologies Ltd (CVALF) - Net Assets
Latest net assets as of September 2025: $30.73 Million USD
Based on the latest financial reports, Covalon Technologies Ltd (CVALF) has net assets worth $30.73 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($36.12 Million) and total liabilities ($5.40 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $30.73 Million |
| % of Total Assets | 85.06% |
| Annual Growth Rate | 3.1% |
| 5-Year Change | -7.93% |
| 10-Year Change | 706.91% |
| Growth Volatility | 75.0 |
Covalon Technologies Ltd - Net Assets Trend (2007–2025)
This chart illustrates how Covalon Technologies Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Covalon Technologies Ltd (2007–2025)
The table below shows the annual net assets of Covalon Technologies Ltd from 2007 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $30.73 Million | +11.72% |
| 2024-09-30 | $27.50 Million | +46.36% |
| 2023-09-30 | $18.79 Million | -22.44% |
| 2022-09-30 | $24.23 Million | -27.40% |
| 2021-09-30 | $33.37 Million | +266.48% |
| 2020-09-30 | $9.11 Million | -39.00% |
| 2019-09-30 | $14.93 Million | +13.76% |
| 2018-09-30 | $13.12 Million | +46.14% |
| 2017-09-30 | $8.98 Million | +135.85% |
| 2016-09-30 | $3.81 Million | -20.43% |
| 2015-09-30 | $4.79 Million | -3.04% |
| 2014-09-30 | $4.94 Million | +72.75% |
| 2013-09-30 | $2.86 Million | -13.24% |
| 2012-09-30 | $3.29 Million | -50.70% |
| 2011-09-30 | $6.68 Million | -9.18% |
| 2010-09-30 | $7.36 Million | -28.11% |
| 2009-09-30 | $10.23 Million | -27.45% |
| 2008-09-30 | $14.11 Million | -20.51% |
| 2007-09-30 | $17.74 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Covalon Technologies Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3363840200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $64.37 Million | 209.48% |
| Total Equity | $30.73 Million | 100.00% |
Covalon Technologies Ltd Competitors by Market Cap
The table below lists competitors of Covalon Technologies Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Busan Ind
KO:011390
|
$26.52 Million |
|
Hotel Property Investments Ltd
AU:HPI
|
$26.52 Million |
|
Evertex Fabrinology Ltd
TW:1470
|
$26.53 Million |
|
Purit Co. Ltd.
KQ:445180
|
$26.53 Million |
|
Fountain Set (Holdings) Limited
F:FOV
|
$26.51 Million |
|
Huvis Corporation
KO:079980
|
$26.51 Million |
|
Golden State Bancorp
OTCQX:GSBX
|
$26.51 Million |
|
RFTech Co. Ltd
KQ:061040
|
$26.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Covalon Technologies Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 27,504,608 to 30,726,909, a change of 3,222,301 (11.7%).
- Net income of 2,058,089 contributed positively to equity growth.
- Other factors increased equity by 1,164,212.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.06 Million | +6.7% |
| Other Changes | $1.16 Million | +3.79% |
| Total Change | $- | 11.72% |
Book Value vs Market Value Analysis
This analysis compares Covalon Technologies Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.52x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-09-30 | $0.00 | $1.70 | x |
| 2016-09-30 | $0.00 | $1.70 | x |
| 2017-09-30 | $0.42 | $1.70 | x |
| 2018-09-30 | $0.60 | $1.70 | x |
| 2019-09-30 | $0.58 | $1.70 | x |
| 2020-09-30 | $0.35 | $1.70 | x |
| 2021-09-30 | $1.29 | $1.70 | x |
| 2022-09-30 | $0.96 | $1.70 | x |
| 2023-09-30 | $0.76 | $1.70 | x |
| 2024-09-30 | $1.00 | $1.70 | x |
| 2025-09-30 | $1.12 | $1.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Covalon Technologies Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.70%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.27%
- • Asset Turnover: 0.91x
- • Equity Multiplier: 1.18x
- Recent ROE (6.70%) is above the historical average (-7.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 0.00% | 0.00% | 0.08x | 1.15x | $-1.77 Million |
| 2008 | 0.00% | 0.00% | 0.11x | 1.15x | $-1.41 Million |
| 2009 | 0.00% | 0.00% | 0.16x | 1.18x | $-1.02 Million |
| 2010 | 0.00% | 0.00% | 0.31x | 1.36x | $-735.59K |
| 2011 | 0.00% | 0.00% | 0.28x | 1.33x | $-668.03K |
| 2012 | 0.00% | 0.00% | 0.64x | 1.84x | $-329.33K |
| 2013 | 0.00% | 0.00% | 0.73x | 1.92x | $-285.74K |
| 2014 | 43.45% | 26.51% | 1.14x | 1.44x | $1.65 Million |
| 2015 | -19.68% | -12.41% | 0.99x | 1.59x | $-1.42 Million |
| 2016 | -81.28% | -46.12% | 1.03x | 1.70x | $-3.48 Million |
| 2017 | 20.17% | 6.63% | 2.28x | 1.33x | $913.59K |
| 2018 | 12.33% | 6.05% | 1.36x | 1.50x | $305.17K |
| 2019 | -61.20% | -26.87% | 0.86x | 2.65x | $-10.63 Million |
| 2020 | -76.34% | -26.95% | 0.74x | 3.81x | $-7.86 Million |
| 2021 | 70.34% | 120.02% | 0.48x | 1.22x | $20.14 Million |
| 2022 | -39.88% | -53.25% | 0.60x | 1.25x | $-12.09 Million |
| 2023 | -23.74% | -16.77% | 1.07x | 1.33x | $-6.34 Million |
| 2024 | 9.71% | 8.57% | 0.98x | 1.16x | $-80.67K |
| 2025 | 6.70% | 6.27% | 0.91x | 1.18x | $-1.01 Million |
Industry Comparison
This section compares Covalon Technologies Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Covalon Technologies Ltd (CVALF) | $30.73 Million | 0.00% | 0.18x | $26.51 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |